Another "Random Bear" - wink wink ; - )I'd check the Bear's history, he signed up on the back of the "top-line data" fiasco. It's no wonder when the phone rang, the corner office assumed it must be Don.
I wonder how far peeps are willing to push the envelope....HOW BIG is this story?
How many Stockhouse ID's will be created to dis-credit this seemingly famous Stockhouse poster?
Too bad the 1 PENNY BID, 1 PENNY ASK on the morning of October 3rd 2016 didn't "shoe him/her/it away ; - )..it did summon the "Bear from the woods" LOL..too funny Beech ; - )
The story from the dredging analyst and the pal from Queens wasn't good enough either..SHOCKING that drinking Polymyxin B straight UP could be deadly, even in 1979 ; - )
If the IRS were to check your account..what might they find? ; - )
I've never seen so many people obsessessed with one "phantom poster"....you Canadiens sure do like creating bullboard tales....I'll bet your stockings are nicley stuffed...and not just at Christmas. I see the SEC involved in so many pump and dump scandals...
where is the USGA when it comes to identifying "sandbaggers"? wink, wink once more ; - )
I think gadgie said it best....too bad this anti-promotional wave is "perpetual"...but perhapd the ultimate prize makes it all too worthwhile??
INDEED..do your OWN due diligence and remember the internet can be an awfully dirty and misleading place to absorb "tales"
The anti- promotional trends must be random
But...perhaps the most BULLISH signal you will ever find.. in my humble and highly educated retail shareholder opinion.
Rather than stories of Influential types loading up, we get misleading and useless numbers of those NOt in the phase 3 trial along with 4 and 5 cent SP targets on the back of data that now leads us straight to a FDA phase 4 confirmatory trial in a critical care life and death scenario where a 2 to 1 ratio has been deployed in favour of our medical device guided by an already FDA approved diagnostic. The wholly-owned diagnostic, though publically questioned for "specifity" forms a theranostic approach to the largest unmet need in critical care medicine. There is so much more, not to mention the curious accounting that has allowed for favourable financing to our CEO's former employer and millions of cheap options to the fortunate inner circle.
I'm sure the posters here apologizing for the anti promotional activity are just random types with little to no other interests...
I love the company and am one of the larger retail holders, fingers crossed we dont keep achieving approvals and multi million $ hand outs from major pharmas, it has proven costly!!!
What would be really funny would be critically important medical types questioning our cost to efficacy situation in a public Q & A and then filling their pockets with cheap handouts... imagine that! Call it option dredging eh David?
It stinks... like old musty money.. looks like sn old boys club and as we age we join membership whether they like it or not.
Best,
Gadge